National Health (Pharmaceutical Benefits Therapeutic Groups) Amendment Determination 2013 (No. 2) (No. PB 7 of 2013) (Cth)

Case

PB 7 of 2013

National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 2)1

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.

Dated         27      March 2013

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

  1. Name of Determination

(1)     This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 2).

(2)     This Determination may also be cited as PB 7 of 2013.

  1. Commencement

This Determination commences on 1 April 2013.

3              Amendments to PB 1 of 2010

Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).

Schedule 1             Amendments

[1]      Schedule 1, Part 4

omit:

1

Cimetidine

[2]      Schedule 1, Part 4

omit:

4

Ranitidine

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0